No Data
Changjiang Pharmaceutical Group (300391.SZ): Subsidiary Changjiang Star has been petitioned for reorganization by creditors.
On February 12, Glorious Hong Kong announced that Changjiang Pharmaceutical Group (300391.SZ) disclosed that its subsidiary Hubei Changjiang Star Pharmaceutical Co., Ltd. (hereinafter referred to as "Changjiang Star") received the acceptance notice for the case from the Intermediate People's Court of Shiyan City, Hubei Province, numbered (2025) E 03 Bankruptcy Application No. 9. The applicant, Wuhan Century Baima System Engineering Co., Ltd., applied to the Shiyan Intermediate Court for the bankruptcy reorganization of Changjiang Star on the grounds that Changjiang Star is unable to pay its due debts and is clearly lacking in repayment ability, but still possesses reorganization value and feasibility. The Shiyan Intermediate Court filed the case on February 11, 2025.
Changyao Holdings: 2024 Annual Results Forecast
Changjiang Pharmaceutical Group (300391.SZ) issued a profit warning, expecting an annual net loss between 0.5 billion yuan and 0.75 billion yuan.
Changjiang Pharmaceutical Group (300391.SZ) disclosed its performance forecast for 2024, estimating that the profit attributable to the shareholders of the listed company...
Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Changjiang Pharmaceutical Group (300391.SZ): Main business includes traditional chinese medicine decoction pieces, pharmaceutical wholesale, photovoltaic equipment, etc.
Changjiang Pharmaceutical Group (300391.SZ) stated on the investor interactive platform on November 12th that the company's main business currently includes traditional chinese medicine decoction pieces, pharmaceutical wholesale, photovoltaic equipment, etc. In addition, its subsidiary Ningxia Chang Pharmaceutical Nutrition has launched a variety of tea drinks and medicinal food homologous products, including 15 kinds of liver-replenishing tea with authentic goji and astragalus as formulas, 20 kinds of moisture-expelling tea, 9 kinds of eight-treasure tea, as well as compressed confectioners and other medicinal food homologous varieties.
Changyao Holdings: Report for the third quarter of 2024
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Surges 52% Yet Its Low P/S Is No Reason For Excitement
